MedPath

Efficacy and Safety of Eyetronix Flicker Glasses to the Treatment of Anisometropic Amblyopia

Not Applicable
Conditions
Amblyopia, Anisometropic
Interventions
Device: EFG group
Device: Patching group
Registration Number
NCT02970708
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Brief Summary

To evaluate the efficacy and safety of Eyetronix Flicker Glassess therapy in treating anisometropic amblyopia.

Detailed Description

A total of 176 children with anisometropic amblyopia, aged 4 to 13 years, will randomize to receive patching or Eyetronix Flicker Glasses treatment in a 1:1 ratio.Eyetronix Flicker Glasses, a lightweight spectacle frame with liquid crystal lenses that provide direct square-wave alternating occlusion, will be used at a pre-programmed temporal frequency. Patching is a traditional treatment of amblyopia. The best corrected visual acuity, contrast sensitivity, binocular function,visual evoked potential and functional MRI will be measured at baseline and follow-up visits to assess the improvement of amblyopia.Feedback information from the questionnaires will be used to evaluate the compliance and adverse effects.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
176
Inclusion Criteria
  1. aged from 4 to 13 years old
  2. the best corrected visual acuity in the amblyopic eye is no more than 0.1logMAR, with two lines or more of difference between the two eyes
  3. anisometropia is defined as an inter-ocular spherical refractive error difference of 1.00 D or more or a cylindrical difference of 1.50 D or more.
  4. no amblyopia treatment one month prior to the study except refractive correction.
  5. myopia is less than -6.00D or hyperopia is less than +9.00D, strabismus was less than 20 prism diopters
  6. willing to participate in this study and be able to follow up on time
Read More
Exclusion Criteria
  1. ocular disease and other disease that have an influence on the visual acuity
  2. history of ocular surgery that have an influence on the visual acuity
  3. the patient is receiving other amblyopia treatment except refractive correction
  4. a family or personal history of seizures
  5. the patient is using some medicine that may have an influence on visual acuity
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EFG groupEFG groupamblyopia in EFG group will receive Eyetronix Flicker Glassess treatment.
Patching groupPatching groupamblyopia in patching group will receive patching treatment.
Primary Outcome Measures
NameTimeMethod
best corrected visual acuity6 months

have an improvement of best corrected visual acuity in the amblyopic eyes

Secondary Outcome Measures
NameTimeMethod
contrast sensitivity function6 months

have an improvement of contrast sensitivity in the amblyopic eyes

visual evoked potential6 months

P100 latency decrease and N75-P100 amplitude increase in the amblyopic eye.

functional MRI6 months

the visual cortex activity have an improvement

stereocuity6 months

have an improvement of stereocuity in the amblyopic eyes

best corrected visual acuitya year and a half

have an improvement of best corrected visual acuity in the amblyopic eyes

© Copyright 2025. All Rights Reserved by MedPath